Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy

被引:18
|
作者
Nghiem, Paul
Bhatia, Shailender
Brohl, Andrew Scott
Hamid, Omid
Mehnert, Janice M.
Terheyden, Patrick
Shih, Kent C.
Brownell, Isaac
Lebbe, Celeste
Lewis, Karl D.
Linette, Gerald P.
Milella, Michele
Hennessy, Meliessa
Bajars, Marcis
Hicking, Christine
D'Angelo, Sandra P.
机构
[1] Univ Washington, Med Ctr, South Lake Union, Seattle, WA 98195 USA
[2] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Angeles Clin & Res Inst, Los Angeles, CA USA
[5] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[6] Univ Lubeck, Dept Dermatol, Lubeck, Germany
[7] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[8] NCI, Bethesda, MD 20892 USA
[9] Univ Paris Diderot, CIC Dept, AP HP, Paris, France
[10] Univ Paris Diderot, Dept Dermatol, AP HP, Paris, France
[11] Univ Colorado Denver, Sch Med, Aurora, CO USA
[12] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[13] IRCCS, Ist Nazl Tumori Regina Elena, Rome, Italy
[14] EMD Serono Inc, Billerica, MA USA
[15] Merck KGaA, Darmstadt, Germany
[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[17] Weill Cornell Med Coll, New York, NY USA
关键词
D O I
10.1200/JCO.2018.36.15_suppl.9507
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9507
引用
收藏
页数:2
相关论文
共 42 条
  • [41] Enlarge-Lung: Two-Year Follow-Up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NiS Enlarge) of Nivolumab after Prior Chemotherapy in Germany
    Groeschell, Andreas
    Schumann, Christian
    Guetz, Sylvia
    Schulz, Holger
    Mueller-Huesmann, Harald
    Schulte, Clemens
    Liersch, Ruediger
    von der Heyde, Eyck
    Wuensch, Verena
    Sebastian, Martin
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 117 - 118
  • [42] ENLARGE-Lung: Two-Year Follow-up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NIS ENLARGE) of Nivolumab after Prior Chemotherapy in Germany
    Guetz, S.
    Schumann, C.
    Groeschel, M.
    Schulte, C.
    Schulz, H.
    Mueller-Huesmann, H.
    Liersch, R.
    von der Heyde, E.
    Wuensch, V
    Sebastian, M.
    PNEUMOLOGIE, 2020, 74 : S38 - S38